NO20034386D0 - Fast farmasöytisk preparat omfattende 4-cyano-trifluor-3-(4- fluorfenylsulfonyl)-2-hydroksy-2-metylpropiono-m-toluidid og PVP - Google Patents

Fast farmasöytisk preparat omfattende 4-cyano-trifluor-3-(4- fluorfenylsulfonyl)-2-hydroksy-2-metylpropiono-m-toluidid og PVP

Info

Publication number
NO20034386D0
NO20034386D0 NO20034386A NO20034386A NO20034386D0 NO 20034386 D0 NO20034386 D0 NO 20034386D0 NO 20034386 A NO20034386 A NO 20034386A NO 20034386 A NO20034386 A NO 20034386A NO 20034386 D0 NO20034386 D0 NO 20034386D0
Authority
NO
Norway
Prior art keywords
drug
alpha
methylpropiono
toluidide
pvp
Prior art date
Application number
NO20034386A
Other languages
English (en)
Other versions
NO20034386L (no
Inventor
Julie Kay Cahill
Nicola Frances Bateman
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27354679&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20034386(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from SE0101171A external-priority patent/SE0101171D0/xx
Priority claimed from SE0102957A external-priority patent/SE0102957D0/xx
Priority claimed from SE0103565A external-priority patent/SE0103565D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20034386D0 publication Critical patent/NO20034386D0/no
Publication of NO20034386L publication Critical patent/NO20034386L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
NO20034386A 2001-04-02 2003-10-01 Fast farmasöytisk preparat omfattende 4-cyano-trifluor-3-(4- fluorfenylsulfonyl)-2-hydroksy-2-metylpropiono-m-toluidid og PVP NO20034386L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE0101171A SE0101171D0 (sv) 2001-04-02 2001-04-02 Pharmaceutical formulation
SE0102957A SE0102957D0 (sv) 2001-09-04 2001-09-04 Pharmaceutical formulation
SE0103565A SE0103565D0 (sv) 2001-10-25 2001-10-25 Pharmaceutical formulation
PCT/GB2002/001439 WO2002080902A1 (en) 2001-04-02 2002-03-27 Solid pharmaceutical composition comprising 4 -cyano-trifluoro-3-(4-fluorophenylsulphonyl)-2-hydroxy-2-methylpropiono- m toluidide and pvp

Publications (2)

Publication Number Publication Date
NO20034386D0 true NO20034386D0 (no) 2003-10-01
NO20034386L NO20034386L (no) 2003-11-28

Family

ID=27354679

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034386A NO20034386L (no) 2001-04-02 2003-10-01 Fast farmasöytisk preparat omfattende 4-cyano-trifluor-3-(4- fluorfenylsulfonyl)-2-hydroksy-2-metylpropiono-m-toluidid og PVP

Country Status (21)

Country Link
US (1) US20040138299A1 (no)
EP (1) EP1381358B1 (no)
JP (1) JP2004525164A (no)
KR (1) KR20030087048A (no)
CN (1) CN1536993A (no)
AT (1) ATE324886T1 (no)
BR (1) BR0208421A (no)
CA (1) CA2443040A1 (no)
CZ (1) CZ20032647A3 (no)
DE (1) DE60211139T2 (no)
EE (1) EE200300476A (no)
ES (1) ES2261655T3 (no)
HU (1) HUP0303454A3 (no)
IL (1) IL157955A0 (no)
IS (1) IS6970A (no)
MX (1) MXPA03008999A (no)
NO (1) NO20034386L (no)
NZ (1) NZ528284A (no)
PL (1) PL365330A1 (no)
SK (1) SK12032003A3 (no)
WO (1) WO2002080902A1 (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK10722003A3 (sk) * 2001-02-27 2004-02-03 Astrazeneca Ab Farmaceutická formulácia obsahujúca bicalutamid v pevnej disperzii s enterickým polymérom a jej použitie
SE0103424D0 (sv) * 2001-10-15 2001-10-15 Astrazeneca Ab Pharmaceutical formulation
SE0103838D0 (sv) * 2001-11-16 2001-11-16 Astrazeneca Ab Pharmaceutical formulation & product
US20050008691A1 (en) * 2003-05-14 2005-01-13 Arturo Siles Ortega Bicalutamide compositions
JP2008521827A (ja) * 2004-11-29 2008-06-26 ノバルティス アクチエンゲゼルシャフト Ｓ１ｐ受容体アゴニストの投与レジメン
JP2008531531A (ja) * 2005-02-23 2008-08-14 アストラゼネカ アクチボラグ 方法
US7785629B2 (en) * 2005-06-21 2010-08-31 Helm Ag Bicalutamide-adsorbates, process for preparing same, and pharmaceutical compositions thereof
CN101272848B (zh) * 2005-07-28 2013-03-13 Isp投资有限公司 改进喷雾干燥的粉末和颗粒材料性质的方法，以及由此生产的产品
US20080045600A1 (en) * 2006-08-17 2008-02-21 Gawande Rahul S Bicalutamide compositions
WO2008076780A2 (en) * 2006-12-14 2008-06-26 Isp Investments Inc. Amorphous valsartan and the production thereof
EP2125938A2 (en) * 2007-01-26 2009-12-02 Isp Investments Inc. Formulation process method to produce spray dried products
WO2009115954A1 (en) 2008-03-17 2009-09-24 Actelion Pharmaceuticals Ltd Dosing regimen for a selective s1p1 receptor agonist
US9018253B2 (en) 2010-07-02 2015-04-28 Bio-Pharm Solutions Co., Ltd. Phenylcarbamate compound and muscle relaxant containing the same
WO2012096458A2 (en) 2011-01-13 2012-07-19 Bio-Pharm Solutions Co., Ltd. Process for preparation of phenyl carbamate derivatives
CN104136413B (zh) 2011-12-27 2016-10-26 比皮艾思药物研发有限公司 用于预防或治疗癫痫症的苯基氨基甲酸酯化合物
TW201431570A (zh) 2012-11-22 2014-08-16 Ucb Pharma Gmbh 用於經皮投服羅替戈汀（Ｒｏｔｉｇｏｔｉｎｅ）之多天式貼片
BR112015032929B1 (pt) 2013-07-03 2022-08-23 Lts Lohmann Therapie-Systeme Ag Sistema terapêutico transdérmico com componente eletrônico e métodos de produção de um sistema terapêutico transdérmico
CN106456566B (zh) 2014-05-20 2020-06-16 Lts勒曼治疗系统股份公司 含罗替戈汀的经皮递送系统
CN106456567A (zh) 2014-05-20 2017-02-22 Lts勒曼治疗系统股份公司 在经皮递送系统中调节活性剂释放的方法
US11752110B2 (en) 2014-05-20 2023-09-12 Lts Lohmann Therapie-Systeme Ag Transdermal delivery system including an interface mediator
MD3226843T2 (ro) 2014-12-05 2021-10-31 Aragon Pharmaceuticals Inc Compoziții anticancer
DK3226842T3 (da) 2014-12-05 2021-01-25 Aragon Pharmaceuticals Inc Anticancersammensætninger

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2181358A1 (en) * 1994-01-21 1995-07-27 Nancy M. Gray Methods and compositions for treating androgen-dependent diseases using optically pure r-(-)-casodex
ES2307482T3 (es) * 1999-02-10 2008-12-01 Pfizer Products Inc. Dispersiones farmaceuticas solidas.
GB9930839D0 (en) * 1999-12-30 2000-02-16 Pharmacia & Upjohn Spa Process for treating gynecomastia

Also Published As

Publication number Publication date
SK12032003A3 (sk) 2004-03-02
EP1381358B1 (en) 2006-05-03
KR20030087048A (ko) 2003-11-12
JP2004525164A (ja) 2004-08-19
DE60211139D1 (de) 2006-06-08
ES2261655T3 (es) 2006-11-16
EE200300476A (et) 2003-12-15
HUP0303454A3 (en) 2005-12-28
BR0208421A (pt) 2004-03-30
US20040138299A1 (en) 2004-07-15
PL365330A1 (en) 2004-12-27
NZ528284A (en) 2005-04-29
NO20034386L (no) 2003-11-28
HUP0303454A2 (hu) 2004-01-28
IL157955A0 (en) 2004-03-28
CN1536993A (zh) 2004-10-13
CZ20032647A3 (cs) 2004-09-15
IS6970A (is) 2003-09-29
MXPA03008999A (es) 2004-02-12
ATE324886T1 (de) 2006-06-15
CA2443040A1 (en) 2002-10-17
DE60211139T2 (de) 2007-03-01
EP1381358A1 (en) 2004-01-21
WO2002080902A1 (en) 2002-10-17

Similar Documents

Publication Publication Date Title
NO20034386D0 (no) Fast farmasöytisk preparat omfattende 4-cyano-trifluor-3-(4- fluorfenylsulfonyl)-2-hydroksy-2-metylpropiono-m-toluidid og PVP
UY27186A1 (es) Formulación farmacéutica
ATE468332T1 (de) Phenyl-(4-(3-phenyl-1h-pyrazol-4-yl)-pyrimidin- - yi)aminderivate
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
GEP20053673B (en) Aryl or Heteroaryl Fused Imidazole Compounds as Anti-Inflammatory and Analgesic Agents
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
GEP20053675B (en) Pyridazinone Aldose Reductase Inhibitors
ATE381537T1 (de) Formanilid-derivative als beta2-adrenorezeptor- agonisten
DK1256339T3 (da) Transdermalt terapeutisk system for opnåelse af høje plasmaniveauer af rotigotin i behandlingen af Parkinsons sygdom
ES2187300A1 (es) Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos.
NO20034204D0 (no) Farmasöytiske kombinasjoner til behandling av kreft
MXPA05011076A (es) Derivados de quinazolina para el tratamiento de cancer.
BR0207316A (pt) Derivados de epotilona para o tratamento de tumores refratários
ATE478662T1 (de) Arzneilösungen enthaltend modafinilverbindungen
SE0103424D0 (sv) Pharmaceutical formulation
TW200505452A (en) Chemical compounds
HUP0300709A2 (hu) Pemetrexedet monotioglikollal, L-ciszteinnel vagy tioglikolsavval együtt tartalmazó gyógyászati készítmény
SE0102440D0 (sv) New compound
BR0017120A (pt) Composição farmacêutica
SE0103839D0 (sv) Pharmaceutical formulation & product
SE0103838D0 (sv) Pharmaceutical formulation & product
NO20026032D0 (no) Farnesyltransferasehemmende 1,2-annelert kinolinenantiomer
SE0102887D0 (sv) New formulation
ATE300281T1 (de) Entzündungshemmende arzneizubereitungen enthaltend ketoprofen
SE0203817D0 (sv) New composition

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application